photo_2020-08-08_23-07-50
Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain
Essential Pharmaceuticals Antibody Hybridomax Titer Production Without Impacting Glycosylation for Cell Culture & Cell Therapy – Biotechnologies
Research and Development Cell-Ess for Biopharmaceutical hybridomas and Clin-Ess for Tissue preservation